特稿：恶性高热研究和患者护理的未来方向。
Special article: Future directions in malignant hyperthermia research and patient care.
机构信息
MHAUS, 1 North Main St, PO Box 1069, Sherburne, NY 13460, USA.
出版信息
Anesth Analg. 2011 Nov;113(5):1108-19. doi: 10.1213/ANE.0b013e318222af2e. Epub 2011 Jun 27.
Abstract
Malignant hyperthermia (MH) is a complex pharmacogenetic disorder of muscle metabolism. To more closely examine the complexities of MH and other related muscle disorders, the Malignant Hyperthermia Association of the United States (MHAUS) recently sponsored a scientific conference at which an interdisciplinary group of experts gathered to share new information and ideas. In this Special Article, we highlight key concepts and theories presented at the conference along with exciting new trends and challenges in MH research and patient care.
摘要
恶性高热（MH）是一种复杂的肌肉代谢遗传药理学疾病。为了更深入地研究 MH 和其他相关肌肉疾病的复杂性，美国恶性高热协会（MHAUS）最近举办了一次科学会议，邀请了一组跨学科的专家齐聚一堂，分享新信息和新想法。在这篇特稿中，我们重点介绍了会议上提出的关键概念和理论，以及 MH 研究和患者护理方面令人兴奋的新趋势和挑战。
相似文献
1
Special article: Future directions in malignant hyperthermia research and patient care.特稿：恶性高热研究和患者护理的未来方向。
Anesth Analg. 2011 Nov;113(5):1108-19. doi: 10.1213/ANE.0b013e318222af2e. Epub 2011 Jun 27.
2
Malignant hyperthermia and the clinical significance of type-1 ryanodine receptor gene (RYR1) variants: proceedings of the 2013 MHAUS Scientific Conference.恶性高热与1型兰尼碱受体基因（RYR1）变异的临床意义：2013年MHAUS科学会议论文集
Can J Anaesth. 2014 Nov;61(11):1040-9. doi: 10.1007/s12630-014-0227-5. Epub 2014 Sep 5.
3
[Malignant hyperthermia--diagnostics, treatment and anaesthetic management].[恶性高热——诊断、治疗及麻醉管理]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2009 Nov;44(11-12):758-63; quiz 764. doi: 10.1055/s-0029-1242125. Epub 2009 Nov 16.
4
[Anesthetic malignant hyperthermia: what's new in 2012?].[麻醉相关恶性高热：2012年有哪些新进展？]
Ann Fr Anesth Reanim. 2013 Jan;32(1):e43-7. doi: 10.1016/j.annfar.2012.10.024. Epub 2013 Jan 3.
5
[Malignant hyperthermia. The ugly].[恶性高热。可怕之处]
Anaesthesist. 2007 Sep;56(9):923-9. doi: 10.1007/s00101-007-1218-5.
6
Ryanodine receptor mutations in malignant hyperthermia and central core disease.恶性高热和中央轴空病中的兰尼碱受体突变
Hum Mutat. 2000;15(5):410-7. doi: 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D.
7
Hypothesis: exertional heat stroke-induced myopathy and genetically inherited malignant hyperthermia represent the same disorder, the human stress syndrome.假设：劳力性热射病诱发的肌病与遗传性恶性高热代表同一种疾病，即人类应激综合征。
Cell Biochem Biophys. 2014 Nov;70(2):1325-9. doi: 10.1007/s12013-014-0059-5.
8
[Malignant hyperthermia].[恶性高热]
Anaesthesist. 1994 Aug;43(8):557-69. doi: 10.1007/s001010050093.
9
[Malignant hyperthermia syndrome in the intensive care unit : Differential diagnosis and acute measures].[重症监护病房中的恶性高热综合征：鉴别诊断与急救措施]
Med Klin Intensivmed Notfmed. 2016 Jun;111(5):407-16. doi: 10.1007/s00063-016-0173-9. Epub 2016 Jun 7.
10
Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia?劳力性热射病与恶性高热易感性之间是否存在关联？
PLoS One. 2015 Aug 10;10(8):e0135496. doi: 10.1371/journal.pone.0135496. eCollection 2015.
引用本文的文献
1
Association of malignant hyperthermia and exertional heat illness in young athletes: An analysis of awareness among clinical and athletic first responders.年轻运动员中恶性高热与运动性热疾病的关联：对临床及运动急救人员认知情况的分析
Saudi J Anaesth. 2024 Apr-Jun;18(2):224-230. doi: 10.4103/sja.sja_858_23. Epub 2024 Mar 14.
2
Pediatric Hyperglycemic Hyperosmolar Syndrome: A Comprehensive Approach to Diagnosis, Management, and Complications Utilizing Novel Summarizing Acronyms.小儿高血糖高渗综合征：一种利用新型总结首字母缩略词进行诊断、管理及并发症处理的综合方法
Children (Basel). 2023 Oct 31;10(11):1773. doi: 10.3390/children10111773.
3
An Assessment of Penetrance and Clinical Expression of Malignant Hyperthermia in Individuals Carrying Diagnostic Ryanodine Receptor 1 Gene Mutations.携带诊断性兰尼碱受体 1 基因突变个体的恶性高热外显率和临床表型评估。
Anesthesiology. 2019 Nov;131(5):983-991. doi: 10.1097/ALN.0000000000002813.
4
Malignant Hyperthermia.恶性高热
Mo Med. 2019 Mar-Apr;116(2):154-159.
5
Nitric Oxide-induced Activation of the Type 1 Ryanodine Receptor Is Critical for Epileptic Seizure-induced Neuronal Cell Death.一氧化氮诱导的1型兰尼碱受体激活对癫痫发作诱导的神经元细胞死亡至关重要。
EBioMedicine. 2016 Sep;11:253-261. doi: 10.1016/j.ebiom.2016.08.020. Epub 2016 Aug 13.
6
The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.返回下一代基因组测序偶然发现结果的成本效益
Genet Med. 2015 Jul;17(7):587-95. doi: 10.1038/gim.2014.156. Epub 2014 Nov 13.
7
Life-threatening heat stroke presenting with ST elevations: a report of consecutive cases during the heat wave in Austria in July 2013.伴有ST段抬高的危及生命的中暑：2013年7月奥地利热浪期间连续病例报告
Wien Klin Wochenschr. 2014 Aug;126(15-16):491-4. doi: 10.1007/s00508-014-0531-7. Epub 2014 Mar 25.
8
Malignant hyperthermia crisis: optimizing patient outcomes through simulation and interdisciplinary collaboration.恶性高热危象：通过模拟和多学科协作优化患者预后
AORN J. 2014 Feb;99(2):301-8; quiz 309-11. doi: 10.1016/j.aorn.2013.06.012.
9
Malignant hyperthermia.恶性高热
Korean J Anesthesiol. 2012 Nov;63(5):391-401. doi: 10.4097/kjae.2012.63.5.391. Epub 2012 Nov 16.
10
Anesthesia advanced circulatory life support.麻醉先进的循环生命支持。
Can J Anaesth. 2012 Jun;59(6):586-603. doi: 10.1007/s12630-012-9699-3. Epub 2012 Apr 21.
本文引用的文献
1
Activated charcoal effectively removes inhaled anesthetics from modern anesthesia machines.活性炭能有效清除现代麻醉机吸入麻醉剂。
Anesth Analg. 2011 Jun;112(6):1363-70. doi: 10.1213/ANE.0b013e318213fad7. Epub 2011 May 5.
2
Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice.恶性高热易患患者现代麻醉工作站的准备：对过去和现在做法的回顾。
Anesthesiology. 2011 Jan;114(1):205-12. doi: 10.1097/ALN.0b013e3181ee2cb7.
3
Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum.源自肌浆网的肌肉疾病和功能障碍的机制模型。
Biochim Biophys Acta. 2011 May;1813(5):948-64. doi: 10.1016/j.bbamcr.2010.11.009. Epub 2010 Nov 27.
4
Statins alter intracellular calcium homeostasis in malignant hyperthermia susceptible individuals.他汀类药物改变恶性高热易感个体细胞内钙稳态。
Cardiovasc Ther. 2010 Dec;28(6):356-60. doi: 10.1111/j.1755-5922.2010.00237.x. Epub 2010 Oct 19.
5
Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse model.丹曲林钠，一种治疗恶性高热的药物，可抑制 RyR2(R2474S/+) 基因敲入小鼠模型中的儿茶酚胺多形性室性心动过速。
Circ J. 2010 Nov;74(12):2579-84. doi: 10.1253/circj.cj-10-0680. Epub 2010 Oct 7.
6
Increased store-operated Ca2+ entry in skeletal muscle with reduced calsequestrin-1 expression.肌质网钙结合蛋白 1 表达减少导致骨骼肌中钙库操纵性钙内流增加。
Biophys J. 2010 Sep 8;99(5):1556-64. doi: 10.1016/j.bpj.2010.06.050.
7
Novel missense mutations and unexpected multiple changes of RYR1 gene in 75 malignant hyperthermia families.75 个恶性高热家系中 RYR1 基因的新型错义突变和意外的多个变化。
Clin Genet. 2011 May;79(5):438-47. doi: 10.1111/j.1399-0004.2010.01493.x.
8
Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations.使用SIFT和PolyPhen预测功能丧失和功能获得性突变。
Genet Test Mol Biomarkers. 2010 Aug;14(4):533-7. doi: 10.1089/gtmb.2010.0036.
9
Store-operated Ca2+ entry in malignant hyperthermia-susceptible human skeletal muscle.易发生恶性高热的人类骨骼肌中的钙库操纵性钙内流。
J Biol Chem. 2010 Aug 13;285(33):25645-53. doi: 10.1074/jbc.M110.104976. Epub 2010 Jun 21.
10
A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPR.RYR1（R163C）中引起恶性高热的突变：钙内流、释放和逆行信号到 DHPR 的改变。
J Gen Physiol. 2010 Jun;135(6):619-28. doi: 10.1085/jgp.200910328. Epub 2010 May 17.
Zotero 插件